JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Tel: +1-832-696-8203
Email: [email protected]
Worldwide Distributors
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
Rifampicin is a bactericidal antibiotic drug of the rifamycin group.
Animal models
Male Parkes strain mice (20 ~ 25g) inoculated in the left hind footpad with 1 × 104 viable units of Mycobacterium marinum (M. marinum)
Dosage form
0.003%, 0.01%, 0.03% and 0.1% rifampin in the diet
Administered by oral route
Applications
Rifampin at dosages of 0.003% and 0.01% in the diet was not suppressive to bacillary growth. A dosage of 0.03% resulted in a transient fall in viable bacillary count, which was followed by recovery of growth 10 days after inoculation. The highest dose (0.1%) was highly bactericidal, with the viable count of M. marinum reduced to, and maintained below, the detectable level of 2.0 × 102 organisms per foot pad after 7 days of treatment.
Note
The technical data provided above is for reference only.
References:
1. Banerjee DK, Holmes IB. In vitro and in vivo studies of the action of rifampicin, clofazimine and B1912 on Mycobacterium marinum. Chemotherapy, 1976, 22(3-4): 242-252.
